Venetoclax monotherapy
19-395
Phase 2 small_molecule active
Quick answer
Venetoclax monotherapy for Chronic Lymphocytic Leukemia (CLL) is a Phase 2 program (small_molecule) at Adaptive Biotechnologies Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Adaptive Biotechnologies Corp
- Indication
- Chronic Lymphocytic Leukemia (CLL)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active